TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma.

Christine Alewine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.